0001235802-23-000111.txt : 20231116
0001235802-23-000111.hdr.sgml : 20231116
20231116163728
ACCESSION NUMBER: 0001235802-23-000111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231116
FILED AS OF DATE: 20231116
DATE AS OF CHANGE: 20231116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wambeke David J.
CENTRAL INDEX KEY: 0001971798
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36291
FILM NUMBER: 231415159
MAIL ADDRESS:
STREET 1: 301 CARLSON PARKWAY, SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc.
CENTRAL INDEX KEY: 0001401040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
BUSINESS PHONE: (763) 496-5454
MAIL ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
FORMER COMPANY:
FORMER CONFORMED NAME: DiaMedica Inc.
DATE OF NAME CHANGE: 20070525
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2023-11-16
0
0001401040
DiaMedica Therapeutics Inc.
DMAC
0001971798
Wambeke David J.
301 CARLSON PARKWAY, SUITE 210
MINNEAPOLIS
MN
55305
0
1
0
0
Chief Business Officer
0
Voting Common Shares, no par value per share
2023-11-16
4
P
0
20000
2.46
A
527114
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.42 to $2.49, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
/s/ Amy E. Culbert, attorney-in-fact
2023-11-16